References

American Diabetes Association. (2022). Standards of medical care in diabetes—2022. Diabetes Care, 45(Supplement 1), S1-S256.

​

Centers for Disease Control and Prevention. (2021). National diabetes statistics report, 2020: Estimates of diabetes and its burden in the United States. U.S. Department of Health and Human Services.

​

Mayo Clinic Staff. (2021). Diabetes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444

​

National Institute of Diabetes and Digestive and Kidney Diseases. (2021). Diabetes. https://www.niddk.nih.gov/health-information/diabetes

​

Akilen, R., Tsiami, A., Devendra, D., & Robinson, N. (2010). Cinnamon in glycaemic control: Systematic review and meta analysis. Clinical Nutrition, 29(4), 505–513. https://doi.org/10.1016/j.clnu.2009.12.003

​

Broadhurst, C. L., Polansky, M. M., & Anderson, R. A. (2000). Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. Journal of Agricultural and Food Chemistry, 48(3), 849–852. https://doi.org/10.1021/jf9904517

​

Meng, S., Cao, J., Feng, Q., Peng, J., & Hu, Y. (2013). Roles of chlorogenic acid on regulating glucose and lipids metabolism: A review. Evidence-Based Complementary and Alternative Medicine, 2013, 1–11. https://doi.org/10.1155/2013/801457

​

Beihl, D. A., Liese, A. D., Haffner, S. M. (2009). Sleep Duration as a Risk Factor for Incident Type 2 Diabetes in a Multiethnic Cohort. Annals of Epidemiology, 19(5), 351-357.

​

Tasali, E., Leproult, R., Ehrmann, D. A., Van Cauter, E. (2008). Slow-Wave Sleep and the Risk of Type 2 Diabetes in Humans. Proceedings of the National Academy of Sciences of the United States of America, 105(3), 1044-1049.

​

Knutson, K. L., Ryden, A. M., Mander, B. A., Van Cauter, E. (2006). Role of Sleep Duration and Quality in the Risk and Severity of Type 2 Diabetes Mellitus. Archives of Internal Medicine, 166(16), 1768-1774.